C omposite hemangioendothelioma (CHE) is the most recently described vascular neoplasm of low-malignant potential, showing varying combinations of benign angiomatous lesions, and different subtypes of hemangioendothelioma and angiosarcoma.
58×31×22 mm and contained a subcutaneous bluishpurple circumscribed nodule, 27 mm in diameter.
Histological examination revealed a vascular neoplasm situated mainly within the deep dermis and the subcutaneous fat tissue (Figure 1) .
The tumor consisted of several angiomatous components that merged with each other. The predominant vascular lesion corresponded to retiform hemangioendothelioma (RHE), occupying approximately 45% of the tumor. Other histological patterns included the areas consistent with sinusoidal hemangioma (25%), arteriovenous hemangioma (10%), and angiosarcoma (20%). Areas resembling RHE were composed of long arborizing thin-walled blood vessels, extending between collagen bundles in a retiform pattern. (Figure 2) . A component showing histological features of sinusoidal hemangioma was characterized by closely packed, thinwalled, interconnecting vascular channels lined with bland endothelium without mitotic activity (Figure 3) . Tumor areas consistent with the arteriovenous hemangioma displayed collections of large, thick-walled vessels running from the upper dermis to the subcu-taneous fat (Figure 4) . Angiosarcomatous component showed irregular vascular channels with a complex dissecting and anastomosing growth pattern and frequent intraluminal thrombosis. Several foci of necrosis were present. Endothelial cells exhibited mild-to-moderate nuclear atypia and mitoses: mean 10 per 10 high-power fields (HPFs) with up to 5 mitoses/HPF in the most mitotically active areas ( Figure 5) .
Endothelial cells within all components of the tumor were immunohistochemically positive for factor After the first report of Nayler et al. that included 7 cutaneous CHE cases and 1 in the extracutaneous localization, 1 only 15 additional tumors occuring in the skin/subcutis have been reported so far. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The clinical and histopathological features of these cases in addition to our example are shown in Table 1 .
The ratio of females to males affected was 2.7:1. The age at presentation ranged from 8 to 75 years (mean, 39 years). In 3 patients, CHEs were present from birth. 3, 7 Previously reported CHEs presented as poorly circumscribed single or multinodular (multicentric) lesions on distal extremities, mostly on hands and feet. Two tumors were situated on the thigh and 1 on the back and in axilla, each. CHE in our patient was localized in the skin of the, previously unreported, gluteal region. In the majority of patients, the preoperative duration of CHEs was long (mean, 16 years; range, 1.5-60 years), and in only 5 patients CHEs developed more rapidly within several months.
1,5,6,9,13 Individual tumors measured 8 mm to 300 mm in size (mean, 50.6 mm and median 31 mm).
Within the histological components of CHEs, the most frequent were retiform HE and epithelioid HE, occurring in 91%, (20/22) 1,3,4,6-13 and 86% (19/22) 1,3-10,12,13 of patients, respectively. The present case was also characterized by the dominant component of retiform HE, occupying approximately 45% of the tumor. Areas similar to angiosarcoma were identified in 54.5% (12/22) of all cases, 1,3,6,7,9,10 occupying from less than 1% to 5% when stated. 3, 6, 9 The angiosarcomatous component was more widespread in the CHE reported by Tejera-Vaquerizo et al 10 and in our case, forming 20% of the tumor; nevertheless no recurrent tumor was noted after 30 months and 3 months, respectively. Tumor necrosis was not present in the cases of Nayler et al, 1 and its existence was not mentioned in other CHEs at all except in the gross description of the case of Chu et al. 6 Data regarding the mitotic activity in cutaneous CHE are scarce. Mitoses were noted mainly in the angiosarcoma areas, ranging from few mitoses 1 to 3 to 10 mitoses/10 HPF, 1, 6, 10 similarly to the present case that exhibited 10 mitoses/10 HPF. In the retiform HE component of our case, no mitoses were seen as in the other cases. 1, 6, 11 Exceptionally, Reis-Filho et al recorded 3 mitoses/mm 2 in the retiform HE, in addition to 6 mitoses/mm 2 within the epithelioid HE-component. 3 Most frequent benign vascular component was the spindle cell hemangioma, found in 14/21 (67%) cases, 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] followed by cavernous hemangioma in 4/21 (19%) cases, 3, 6, 7, 9 and arteriovenous malformation and lymphangioma in 3/21 (14%) each. 1, 6, 7 We describe the sinusoidal hemangioma as a benign vascular component of CHE for the first time. Sinusoidal hemangioma is considered to be a variant of cavernous hemangioma, 14, 15 or an uncommon benign vascular tumor with some similarities to a venous malformation ("cavernous hemangioma"). 16 Immunohistochemically, all of the previous cutaneous CHEs expressed 1 or more endothelial markers.
1,3-13 Our case was also positive for CD31, CD34, and factor VIII-related antigen but negative for lymphatic endothelial marker D2-40, like the cases of Fukunaga et al 7 Variable immunopositivity for D2-40, observed in retiform HE component, 12, 13 and positive immunoreactivity for Prox-1 antibody, seen in epithelioid HE component, 8 supported a lymphatic line of differentiation in these cases. 8, 12 HE component 8 supported a lymphatic line of differentiation in these cases. 8, 12 Ki-67 proliferation index has been cited in only 2 reports of CHEs 6, 8 with up to 42% in angiosarcomatous component 6 and 50% in the areas of epithelioid hemangioendothelioma. 8 In our case, angiosarcoma component exhibited Ki-67 positivity in 21% of cells, while in the areas of retiform HE and sinusoidal hemangioma, Ki-67 index was 1.2% and 0%, respectively, reflecting the differences in proliferative activity of various CHE components.
Regarding the biological behavior of CHE, followup data were available in 18 of 22 cases of cutaneous tumors reported previously. Eight patients (44%) were free of the disease, 1,3,10,12,13 7 patients (39%) exhibited 1 or more recurrences or residual disease, 1, 4, 5, 7, 8, 11 and 3 patients (17%) developed metastatic lesions in lymph nodes, including 1 patient with additional liver, lung, and bone metastases. 6, 8, 11 Therefore, 55.5% (10/18) of patients with cutaneous CHE had a recurrent and/or metastatic disease. After excisional therapy, local recurrences developed after several months to 4 years. 1, 4, 5, 7, 8, 11 Lymph node metastases were present either at diagnosis, 6 or they developed after a few months 8 or 2 years.
11 Out of 3 CHEs that metastasized, only 1 primary tumor contained a component of angiosarcoma; nevertheless, the lymph node metastases in this case were composed only of RHE. 6 Lymph node metastases of the other 2 cases of metastatic CHEs displayed epithelioid hemangioendothelioma 8 and small-vessel proliferation with many eosinophils.
11 These findings confirmed the initial view of Nayler et al that the common presence of an apparently angiosarcomatous component was not associated with a worse prognosis as expected in conventional angiosarcoma.
1 CHE should be considered in the differential diagnosis of cutaneous vascular tumors to avoid inappropriately aggressive therapy.
